SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-020276
Filing Date
2020-03-19
Accepted
2020-03-19 16:31:28
Documents
2
Period of Report
2020-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1547
2 POA DOCUMENT poa.txt EX-24.3_905786 4772
  Complete submission text file 0001209191-20-020276.txt   7674
Mailing Address 441 CHARMANY DRIVE MADISON WI 53719
Business Address
Stenhouse Mark (Reporting) CIK: 0001734751 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39094 | Film No.: 20728927

Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Issuer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations